{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:12:59Z","timestamp":1790871179122,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.encep.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T06:27:26Z","timestamp":1461911246000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["R\u00e9introduction de la clozapine apr\u00e8s neutrop\u00e9nie dans la schizophr\u00e9nie r\u00e9sistante\u00a0: revue des donn\u00e9es de la litt\u00e9rature"],"prefix":"10.1016","volume":"42","author":[{"given":"L.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2016.03.005_bib0230","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0013-7006(06)76220-0","article-title":"\u00c9tude retrospective sur l\u2019utilisation de la clozapine en \u00cele-de-France","volume":"32","author":"Hiltgen","year":"2006","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2016.03.005_bib0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine induced agranulocytosis-incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl.","key":"10.1016\/j.encep.2016.03.005_bib0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.917","article-title":"Haematological toxicity of drugs used in psychiatry","volume":"23","author":"Flanagan","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.encep.2016.03.005_bib0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM199307153290312","article-title":"Clozapine-deciphering the risks","volume":"329","author":"Gerson","year":"1993","journal-title":"N Engl J Med"},{"issue":"339","key":"10.1016\/j.encep.2016.03.005_bib0250","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/0140-6736(92)91625-I","article-title":"Rechallenge in clozapine-induced agranulocytosis","volume":"23","author":"Safferman","year":"1992","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.encep.2016.03.005_bib0255","first-page":"882","article-title":"In vitro effect of clozapine on hemopoietic progenitor cells","volume":"83","author":"Deliliers","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.encep.2016.03.005_bib0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hup.1181","article-title":"Haematological toxicity of clozapine and some other drugs used in psychiatry","volume":"26","author":"Nooijen","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.encep.2016.03.005_bib0265","first-page":"245","article-title":"Granulocyte macrophage colony stimulating factor treatment of clozapine induced agranulocytosis: a case report","volume":"53","author":"Barnas","year":"1992","journal-title":"J Clin Psychiatry"},{"issue":"Suppl.\u00a0B","key":"10.1016\/j.encep.2016.03.005_bib0270","first-page":"139","article-title":"GCSF and the management of clozapine induced agranulocytosis","volume":"55","author":"Gerson","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2016.03.005_bib0275","first-page":"256","article-title":"Filgrastim treatment of three patients with clozapine induced agranulocytosis","volume":"56","author":"Lamberti","year":"1995","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2016.03.005_bib0280","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1192\/bjp.162.5.686","article-title":"Clozapine induced agranulocytosis treated with GMCSF","volume":"162","author":"Oren","year":"1993","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2016.03.005_bib0285","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004714-199408000-00015","article-title":"Successful treatment of clozapine induced agranulocytosis with GCSF","volume":"14","author":"Raison","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2016.03.005_bib0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.188.3.255","article-title":"Rechallenge with clozapine following neutropenia or neutropenia during previous therapy","volume":"188","author":"Dunk","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2016.03.005_bib0295","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","article-title":"When can patients with potentially life threatening adverse effects be rechallenged with clozapine?. A systematic review of the published literature","volume":"134","author":"Manu","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2016.03.005_bib0300","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.pnpbp.2008.03.001","article-title":"Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agents","volume":"32","author":"Wu","year":"2008","journal-title":"Progr NeuroPsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2016.03.005_bib0305","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1099-1077(200006)15:4<275::AID-HUP171>3.3.CO;2-V","article-title":"A second trial of clozapine in a case of granulocytopenia","volume":"15","author":"Silverstini","year":"2000","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2016.03.005_bib0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004714-199702000-00026","article-title":"Unsuccessful reexposure to clozapine","volume":"17","author":"Szarek","year":"1997","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.encep.2016.03.005_bib0315","doi-asserted-by":"crossref","first-page":"S418","DOI":"10.1016\/S0924-977X(08)70609-6","article-title":"Safe r\u00e9introduction of clozapine: changing trends","volume":"18","author":"Franco","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.encep.2016.03.005_bib0320","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v67n0509","article-title":"Lithium and clozapine rechallenge: a retrospective case analysis","volume":"67","author":"Kanaan","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2016.03.005_bib0325","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00228-004-0835-z","article-title":"Continuing clozapine treatment despite neutropenia","volume":"60","author":"Esposito","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.encep.2016.03.005_bib0330","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1176\/ajp.152.4.648","article-title":"Modification of clozapine induced leukopenia and neutropenia with lithium carbonate","volume":"152","author":"Adityanjee","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2016.03.005_bib0335","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.jcp.0000155831.72154.bc","article-title":"Rechallenge of late neutropenia with clozapine","volume":"25","author":"Small","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2016.03.005_bib0340","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-199802000-00016","article-title":"Prevention of clozapine-induced neutropenia by pretreatment with lithium","volume":"18","author":"Silverstone","year":"1998","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.encep.2016.03.005_bib0345","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1176\/appi.ajp.2008.07111823","article-title":"Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia","volume":"165","author":"Ghaznavi","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2016.03.005_bib0350","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00004714-199412000-00012","article-title":"Unsuccessful reexposure to clozapine","volume":"14","author":"Frankenburg","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2016.03.005_bib0355","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2146\/ajhp060319","article-title":"Clozapine-induced leukopenia successfully treated with lithium","volume":"64","author":"Kutscher","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.encep.2016.03.005_bib0360","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0013-7006(04)95473-5","article-title":"Correction par le lithium des neutrop\u00e9nies induites par la clozapine (deux cas)","volume":"XXX","author":"Papetti","year":"2004","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2016.03.005_bib0365","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.pnpbp.2008.09.005","article-title":"Lithium as a treatment of clozapine-induced neutropenia: a case report","volume":"32","author":"Russowsky Brunoni","year":"2008","journal-title":"Progr NeuroPsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2016.03.005_bib0370","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0022-3859.109496","article-title":"Clozapine re-challenge under the cover of Filgrastim","volume":"59","author":"Gopalakrishnan","year":"2013","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.encep.2016.03.005_bib0375","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.encep.2013.02.003","article-title":"R\u00e9introduction de la clozapine chez les patients souffrant de schizophr\u00e9nie r\u00e9sistante \u00ab\u00a0super r\u00e9pondeurs\u00a0\u00bb, apr\u00e8s neutrop\u00e9nie sous clozapine\u00a0: \u00e0 propos d\u2019un cas","volume":"39","author":"Huguet","year":"2013","journal-title":"Enc\u00e9phale"},{"issue":"2","key":"10.1016\/j.encep.2016.03.005_bib0380","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1192\/bjp.179.2.180","article-title":"An alternative to interruption of treatment in recurrent clozapine-induced severe neutropenia","volume":"179","author":"Conus","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2016.03.005_bib0385","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1176\/appi.ajp.2008.08081295","article-title":"Add on filgrastim during clozapine rechallenge in patients with a history of clozapine related granulocytopenia\/agranulocytosis","volume":"166","author":"Joffe","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2016.03.005_bib0390","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/JCP.0b013e31815a583b","article-title":"Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia","volume":"27","author":"Mathewson","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2016.03.005_bib0395","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/2045125313476877","article-title":"Continuing clozapine with granulocyte colony-stimulating factor in patients with neutropenia. Therap","volume":"3","author":"Khan","year":"2013","journal-title":"Adv Psychopharmacol"},{"issue":"9","key":"10.1016\/j.encep.2016.03.005_bib0400","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1177\/0269881112450782","article-title":"Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe Benign ethnic neutropenia (BEN): a case report","volume":"26","author":"Spencer","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.encep.2016.03.005_bib0405","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0013-7006(04)95462-0","article-title":"Leponex, 10ans apr\u00e8s \u2013 une revue clinique","volume":"XXX","author":"Llorca","year":"2004","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2016.03.005_bib0410","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/S0013-7006(07)78691-8","article-title":"B\u00e9n\u00e9fices compar\u00e9s des antipsychotiques atypiques versus neuroleptiques classiques","volume":"Suppl.\u00a05","author":"Vanelle","year":"2007","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2016.03.005_bib0415","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0013-7006(06)76287-X","article-title":"Apport des antipsychotiques atypiques dans la prise en charge \u00e0 long terme de la schizophr\u00e9nie","volume":"32","author":"Limosin","year":"2006","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2016.03.005_bib0420","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/S0013-7006(08)75518-0","article-title":"Quid des schizophr\u00e9nies r\u00e9sistantes\u00a0?","volume":"Suppl.\u00a06","author":"Garnier","year":"2008","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2016.03.005_bib0425","first-page":"567","article-title":"Neutrop\u00e9nie chez un patient trait\u00e9 avec la clozapine dans le contexte d\u2019une polypharmacie","volume":"28","author":"S\u00e9n\u00e9chal","year":"2002","journal-title":"Enc\u00e9phale"},{"issue":"9","key":"10.1016\/j.encep.2016.03.005_bib0430","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4088\/JCP.v65n0918a","article-title":"Two years follow-up of a patient with successful continuation of clozapine treatment despite morning pseudoneutropenia","volume":"65","author":"Esposito","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2016.03.005_bib0435","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1200\/JCO.2009.24.3881","article-title":"Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?","volume":"28","author":"Hsieh","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.encep.2016.03.005_bib0440","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/0269881110364267","article-title":"The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: case reports and database study","volume":"25","author":"Whiskey","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.encep.2016.03.005_bib0445","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1773-035X(14)72476-1","article-title":"Physiologie des polynucl\u00e9aires neutrophiles humains","volume":"462","author":"Hurtado-Nedelec","year":"2014","journal-title":"Rev Francophone Lab"},{"key":"10.1016\/j.encep.2016.03.005_bib0225","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.encep.2007.01.004","article-title":"Approche pharmacog\u00e9n\u00e9tique de la r\u00e9ponse aux antipsychotiques chez les schizophr\u00e8nes. Revue de la litt\u00e9rature","volume":"33","author":"Moulier","year":"2007","journal-title":"Enc\u00e9phale"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700616300239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700616300239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T21:20:47Z","timestamp":1536787247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700616300239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0013700616300239"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2016.03.005","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9introduction de la clozapine apr\u00e8s neutrop\u00e9nie dans la schizophr\u00e9nie r\u00e9sistante\u00a0: revue des donn\u00e9es de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}